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Development of Watershed Classification Systems
for Diagnosis of Biological Impairment in
Watersheds and Their Receiving Waterbodies
The U.S. Environmental Protection Agency (EPA)
Office of Research and Development is soliciting grant
applications for establishing watershed classification
schemes in different regions of the United States to
support the design of efficient monitoring strategies,
diagnose the causes of biological impairment, and pri-
oritize watersheds for restoration activities. This will
involve defining both the structural characteristics of a
classification strategy (geographic dependence vs. inde-
pendence, scale, hierarchy, discrimination of natural
features from anthropogenic alteration), functional
characteristics (theoretical basis for defining categories),
and pragmatic aspects of implementation (regional and
national relevance, ease of application, flexibility, accu-
racy, nature of technical transfer products).
In risk assessments, classification schemes serve as
an aid for boundary definition in problem formulation
and as a tool for extrapolation of exposure–effect rela-
tionships in risk characterization. Ultimately, water-
shed classification systems can serve as 1) the basis for
stratification in monitoring strategies to detect respons-
es to nonpoint-source pollution, 2) a tool to assess
watershed vulnerability and diagnose potential causes
of biological impairment, 3) a method to prioritize
watersheds for restoration activities, and 4) a tool to
extrapolate results of empirical or mechanistic models
of watershed response to other similar watersheds,
potentially across entire regions. Classification thus
reveals to watershed managers increased opportunities
for risk prevention and locally appropriate goals and
methods for watershed restoration.
This RFA builds upon earlier Science To Achieve
Results grants in aquatic ecosystem classification by
exploring relationships between watershed attributes
and aquatic ecosystem condition. In addition, this
RFA goes beyond the development of methods to
assess current condition by addressing the develop-
ment of methods to assess differences in ecosystem
vulnerability to stressors and differences in restoration
opportunities within a watershed context. The EPA is
interested in building on current classification work by
developing the strong underlying basic science that
establishes a conceptual understanding of how baseline
aquatic ecosystem condition relates to watershed
attributes (physical, climatic, terrestrial) and how
anthropogenic activity alters baseline conditions.
Classification schemes completed through this RFA
will enhance the ability of state, tribal, and local agen-
cies to protect the nation’s waters.
The outcome of the research will help address
these questions: 1) how regionalized watershed classifi-
cation schemes can be developed within the context of
a national framework to determine ecosystem vulnera-
bility and opportunities for watershed restoration; 2)
the degree to which ecologically relevant flow-regime
metrics, including those describing base-flow and
peak-flow conditions, can be predicted based on
watershed characteristics; 3) how functional relation-
ships between watershed attributes and hydrological,
water quality, and biological responses at different
scales can be incorporated into a hierarchical classifica-
tion scheme to predict regional-, watershed-, and
waterbody-scale sensitivities to aquatic nonpoint-
source stressors; 4) the degree to which the sensitivity
of aquatic ecosystems to the effects of anthropogenic
changes to watersheds can be predicted based on the
inherent biophysical characteristics of watersheds; 5)
the degree to which relationships can be quantified
between hydrologic regime and nonpoint-source pol-
lution processes, such as sediment yields, nutrient
loadings, aquatic thermal regimes, and riparian and in-
stream habitat structure and quality, in a watershed;
and 6) the specific environmental problems that might
be amenable to solving with application of the pro-
posed classification scheme.
Successful applications will include development
of a regionalized classification scheme and explicit
information on how the calibration and validation of
the classification scheme would be carried out. The
application must also address all of the following
attributes of watershed classification frameworks: geo-
graphically dependent vs. independent frameworks,
scale, hierarchy, regional relevance, relationship to
impairment, basis for developing categories, and basis
in theory. 
Responses to this solicitation must address how
classification schemes and response models will be test-
ed, either through analysis of existing data or through
collection of new data. Preferably, collection of new
data will be linked to existing monitoring programs,
through collaboration with local, state, or tribal agen-
cies, watershed managers, or other nonprofit organiza-
tions. Applicants must discuss how difficult, expensive,
or practical it would be for others, specifically state
monitoring programs, to apply the classification
methodology themselves. Ideally, watershed classifica-
tion schemes will rely on the use of readily available
GIS data or attributes that can be readily derived from
such data so that they can be applied in the near term
by public agencies. 
Proposals must include a means to assess the level
of accuracy associated with their watershed classifica-
tion system. Applicants are expected to address quality
assurance; see the standard instructions for a discussion
of the statement required with the proposal. Those
proposals recommended for an award will be expected
to provide additional detail. Quality assurance docu-
mentation will need to address how a classification sys-
tem will meet proposed data quality objectives for a
given quality assurance program plan created by a gov-
ernmental management entity. This will help facilitate
coordination with existing regional, state, and/or tribal
monitoring organizations. 
Applicants must specifically address how the
watershed classification scheme will support more effi-
cient monitoring efforts, improve diagnosis of causes of
biological impairment, and/or prioritize watershed
restoration efforts. Results of the proposed research
must be clearly defined. A clear distinction must be
made between outputs and outcomes of the research.
Applicable results include 1) a solid and easily applied
classification methodology, 2) a classified set of water-
sheds for a given region, and 3) a database and/or an
expert system tool for classification. The primary and
essential output will be a classification scheme.
It is anticipated that a total of approximately $4
million will be awarded, depending on the availability
of funds. EPA anticipates funding approximately five
grants under this RFA. The projected award range is
$150,000–300,000 per year ($450,000–900,000 per
grant) including direct and indirect costs for up to
three years, depending on whether new field data are
collected. 
More information on this RFA is available online
at http://es.epa.gov/ncer/rfa/current/2003wshedclass.
html. The deadline for final applications is 29 January
2003. A set of special instructions on how applicants
should apply for this grant is available online at
http://es.epa.gov/ncer/rfa/forms/. The necessary forms
for submitting an application are also provided on this
website. 
Contact: Jonathan H. Smith, 202-564-5181,
e-mail: smith.jonathan@epa.gov. E-mail inquiries
are preferred. Reference: 2003-STAR-A1
Mouse Models of Human Cancers Consortium
The National Cancer Institute (NCI) invites new and
competing renewal cooperative agreement (U01) and
NIH intramural applications from groups of investiga-
tors to continue the Mouse Models of Human
Cancers Consortium (MMHCC). The scientific scope
of this integrative human/mouse cancer research pro-
gram may be expanded through incorporation of indi-
viduals or groups with additional new perspectives and
expertise, such as chemistry, computational and math-
ematical modeling, and systems biology, to create
transdisciplinary approaches to the design, analysis,
and applications of mouse cancer models. 
The intent of the NCI in this RFA is to foster
research investigations, technological innovation, and
extensive collaboration that cannot be pursued with
traditional grant support. Applicants to this RFA are
encouraged to propose risky approaches that incorpo-
rate broad knowledge of human cancer research into
the design, analysis, and applications of mouse cancer
models, and to incorporate biocomputational, mathe-
matical modeling, and systems biology strategies to
inform design of genetic models and their cross-com-
parisons to human cancer. The newly implemented
transdisciplinary nature of the MMHCC will sustain
discoveries that should stimulate mechanistic hypothe-
ses for future research and generate additional tools in
support of translational and clinical cancer science. 
Significant advances in the science of mouse can-
cer modeling reflect the rapid acquisition of mouse and
human genome sequence information, the informatics
tools to analyze and compare them, innovative tech-
nologies to derive molecular signatures of human and
mouse cancer, and the evolution of new approaches to
mouse engineering and phenotyping. As new observa-
tions about human cancer biology emerge, additional
mouse germline or other engineering approaches may
be needed to recapitulate them in mice. 
One key emerging use for mouse cancer models is
as tools for research on interventions—to define mole-
cular targets and to test molecularly targeted agents for
therapy and prevention. Models can be used to illumi-
nate the mechanisms for less-than-optimal clinical
experience of a given agent. To explore how to
improve clinical outcome, researchers can test new
combination therapies in mice; with this strategy, they
often find that the mutated genes drive cancer progres-
sion by a different mechanism than first hypothesized.
Such discoveries can lead to the development of new
classes of agents that reflect better knowledge about the
function of particular genes in tumors. 
Published results of this kind suggest that there
are many potential avenues yet to investigate. It will be
an essential goal of the MMHCC to apply the most
promising cancer models to identify the range of clini-
cal questions for which they are useful. There are many
opportunities to invent and test new delivery systems,
including those enabled by recent advances in nan-
otechnology. In addition, mouse cancer models can be
used to define the genetic determinants of response or
resistance to interventions. 
The NCI anticipates that augmenting the mouse
cancer modeling expertise of the MMHCC with a
broader base of perspectives in the future will enable
the consortium to design and generate additional
mouse cancer models and modeling strategies, invent
new ways and employ existing methods to characterize
the models much more fully for cross-comparisons to
human cancer, substantially expand the repertoire of
applications to many more aspects of human cancer
research, and employ bioinformatics to an unprece-
dented degree to ensure full integration of human and
mouse model cancer research.
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In this RFA, the NCI encourages applications
from groups with broad expertise that may include, but
is not limited to, 1) mouse-related research, such as
genetics, genetic engineering, biology, physiology, and
phenotyping; 2) application of cancer models to
human basic, translational, clinical, and population sci-
ence; 3) application of computational and statistical
sciences, mathematical modeling, and bioinformatics
to integrate human and mouse cancer research; 4) use
of chemistry, genomics, proteomics, imaging, and
image analysis to inform model design, characteriza-
tion, and application; and 5) development of innova-
tive technologies to support derivation, phenotyping,
and translational applications of new or existing mouse
cancer models. 
To implement the MMHCC, the NCI will select
as components up to 18 new and competing renewal
U01 applications and up to 4 NIH intramural pro-
jects, each supporting a multidisciplinary team. Each
component will be a self-assembled team of investiga-
tors who contributes to the MMHCC effort a unique
blend of complementary research experience. 
This RFA will use the NIH U01 award mecha-
nism. The anticipated award date is 1 April 2004. NCI
intends to commit approximately $18 million in fiscal
year 2004 extramural funds to support new and com-
peting renewal grants in response to this RFA.
Applications must be prepared using the PHS 398
research grant application instructions and forms (rev.
5/2001). The PHS 398 is available at http://grants.
nih.gov/grants/funding/phs398/phs398.html in an
interactive format. The deadline for letters of intent is
19 February 2003, with final applications due 19
March 2003. Complete information on this RFA is
available at http://grants1.nih.gov/grants/guide/
rfa-files/RFA-CA-04-002.html. 
Contact: Cheryl L. Marks, Division of Cancer
Biology, NCI, Executive Plaza North, Room 5000,
Bethesda, MD 20892-7380 USA, 301-594-8778, fax:
301-496-8656, e-mail: marksc@mail.nih.gov.
Reference: RFA No. CA-04-002
Continued Development and Maintenance of
Bioinformatics/Computational Biology Software 
Biomedical research laboratories occasionally create
software to solve a problem the laboratory faces.
These software packages sometimes evolve into a well-
designed system that can be easily extended and that
is useful to a much broader community beyond the
members of the originating laboratory. The goal of
this PA is to support the continued development,
maintenance, testing, and evaluation of existing soft-
ware. The proposed work should apply best practices
and proven methods for software design, construc-
tion, and implementation to extend the applicability
of existing bioinformatics–computational biology
software to a broader biomedical research community.
This initiative pertains to bioinformatics/compu-
tational biology software that is recognized to perform
an important function in furthering biomedical
research. The software should perform reliably and pre-
cisely according to the computing demands of end
users. The algorithms that are employed by the soft-
ware should be well documented, as should be the
underlying assumptions of these algorithms to prevent
potential misuse.
Contemporary software must be fully docu-
mented and easy to modify and extend. Defects that
arise in any software must be correctable with limit-
ed effort. As the needs of a community of users
change, the software that supports their research
efforts must be easily modified. Reparability and
evolvability are particularly important because the
scientific discovery process is open-ended and ever-
changing. Interoperability and portability are also a
major concern. Where appropriate, software applica-
tions should operate on a variety of platforms
employing different operating systems. 
Awards made under this PA will support contin-
ued software development, evaluation, and testing of
preexisting bioinformatics/computational biology
software for data management and analysis, compu-
tational biology, and modeling and simulation.
Support will be provided for porting software to new
platforms and operating systems as well as the costs
associated with maintaining the software as existing
operating systems change. The proposed software
should not substantially duplicate another software
package that is already in wide use.
This PA will use the NIH R01 award mecha-
nism as well as competitive supplements to existing
R01, R33, P01, P41, P50, and P60 grants that have
already been awarded by one of the participating
institutes or centers. Applications for competitive
supplements cannot extend beyond the parent pro-
ject period of performance, and the principal investi-
gator must be the same.
Applications must be prepared using the PHS
398 research grant application instructions and forms
(rev. 5/2001). The PHS 398 is available at http://
grants.nih.gov/grants/funding/phs398/phs398.html
in an interactive format. Applications submitted in
response to this PA will be accepted at the standard
application deadlines, available at http://grants.
nih.gov/grants/dates.htm. Application deadlines are
also indicated in the PHS 398 application kit.
Contact: Bret Peterson, NCRR, One Rockledge
Centre, Room 6152, 6705 Rockledge Drive, MSC
7965, Bethesda, MD 20892-7965 USA, 301-435-
0758, fax: 301-480-3659, e-mail: bretp@
ncrr.nih.gov; Yuan Liu, NINDS, Neuroscience
Building, Room 2110, 6001 Executive Boulevard,
MSC 9523, Bethesda, MD 20892-9523 USA, 301-
496-1917, fax: 301-480-2424, e-mail: liuyuan2@
ninds.nih.gov; Karen Skinner, Division of
Neuroscience and Behavior Research, NIDA, Room
4255, 6001 Executive Boulevard, Bethesda, MD
20892-9651 USA, 301-435-0886, fax: 301-594-
6043, e-mail: ks79x@nih.gov; Michael Huerta,
Division of Neuroscience and Basic Behavioral
Science, NIMH, 6001 Executive Boulevard, Room
7202, MSC 9645, Bethesda, MD 20892-9645 USA,
301-443-3563, fax: 301-443-1731, e-mail: mhuer-
ta@helix.nih.gov; James Cassatt, Division of Cell
Biology and Biophysics, NIGMS, 45 Center Drive,
MSC 6200, Bethesda, MD 20892-6200 USA, 301-
594-0828, fax: 301-480-2004, e-mail: cassattj@
nigms.nih.gov; Richard E. Swaja, NIBIB, 6707
Democracy Boulevard, Suite 900, Bethesda, MD
20892-5469 USA, 301-451-4779, fax: 301-480-
4973, e-mail: swajar@nibib.nih.gov; Carol Bean,
Extramural Programs, NLM, One Rockledge
Centre, Suite 301, 6705 Rockledge Drive, Bethesda,
MD 20892 USA, 301-594-4882, fax: 301-402-
2952, e-mail: cb389x@nih.gov; Peter Good,
NHGRI, Building 31, Room B2B07, Bethesda,
MD 20892-2033 USA, 301-435-5796, fax: 301-
480-2770, e-mail: Peter_Good@nih.gov; Ellen
Liberman, NEI, Executive Plaza South, Suite 350,
6120 Executive Boulevard, MSC 7164, Bethesda,
MD 20892-7164 USA, 301-451-2020, fax: 301-
502-0528, e-mail: ellenliberman@nei.nih.gov;
Antonio Norhona, NIAAA, 6000 Executive
Boulevard, Bethesda, MD 20892-7003 USA, 301-
443-7722, fax: 301-594-0673, e-mail:
anoronha@willco.niaaa.nih.gov. Reference: PA No.
PA-02-141
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When it comes to the environment...
YOU CAN’T BELIEVE
EVERYTHING YOU READ
So you’d better know who you can
trust. Environmental Health Perspectives
draws on more than 25 years of scientific
publishing, backed by the authority of
the National Institutes of Health–National
Institute of Environmental Health Sciences,
to provide you with the most current and
credible information available to help
you make decisions about your health
and the environment. 
Each month we delve into the issues you
care about such as:
water, air, and soil pollution
urban sprawl
population and world health
toxic pesticides
environmental products and services
Call 1-866-541-3841 today
to subscribe and visit us online at
ehponline.org